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Abstract 
Background: To study whether medical textbooks are sponsored by drug or device companies, and if so, whether they 
have tried to influence their contents. 
Methods: Cross-sectional study of the medical textbooks written in Danish for graduate clinical courses at the University 
of Copenhagen and anonymous web-based survey of editors. For sponsored books, we also contacted the authors.  
Results: Eleven of 71 medical textbooks (15%) were sponsored. We contacted 11 editors, and for 8 books that had 
authors that were not editors, we also contacted one author. Ten editors and 5 authors replied. One editor was contacted 
5 times by the various sponsors concerning the content of specific chapters and in another case the sponsor had the 
content of a chapter changed regarding its own drug. Two of the authors noted that they did not know that the book was 
sponsored. 
Conclusions: Sponsorship of medical textbooks was not uncommon and may lead to lack of academic freedom. Medical 
students may be particularly vulnerable to commercial influences, as they have had little or no training in commercial 
biases and generally believe what they read in textbooks. 
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Introduction 
The contact with the pharmaceutical industry starts 
early in the medical career. A survey showed that more 
than half of third-year medical students had been 
exposed to industry influences such as free food, small 
non-educational gifts, journal reprints, books and grand 
rounds.1 The students generally had a positive attitude 
towards these activities. To regulate this relationship, 
medical associations, industry and governmental 
authorities have made policies and guidelines2, and 
campaigns have been initiated to draw attention to the 
problem.3-5  
A survey of doctors showed that medical textbooks 
were their preferred information resource.6 Medical 
textbooks are opinion-based and recommendations can 
conflict with the current evidence.7 As textbooks do not 
give the readers the possibility of inspecting the data 
and drawing their own conclusions, biased 
recommendations based on conflicts of interest could 
lead to suboptimal clinical decision making.   
Sponsorship of scientific books has been described in 
relation to the tobacco8,9 and alcohol10 industries. A 
court case concerning off-label promotion of the 
epilepsy drug gabapentin (Neurontin) revealed that 
Warner-Lambert paid over $300,000 to support the 
production, printing and distribution of 75,000 copies of 
an epilepsy textbook.11,12 Half of the budget was 
allocated to soliciting interest among and delivering 
books to high prescribers of anticonvulsant agents. 
Apart from this case, sponsorship of medical textbooks 
has to our knowledge not been described previously and 
has not been investigated empirically. In this study, we 
describe sponsorship of Danish medical textbooks by 
the pharmaceutical and medical device industry and 
report a survey of the editors and authors. 
Methods 
Identification of sponsored textbooks 
In December 2007, one author (AL) examined all 
medical textbooks written in Danish and potentially 
used for the graduate clinical courses in medicine at the 
Medical Faculty, University of Copenhagen available at 
either the University Medical Library or the University 
Medical Bookstore. We defined clinical courses as those 
which address treatment of patients (therefore, for 
example, including pharmacology and microbiology, but 
excluding radiology and occupational medicine). 
Textbooks translated into Danish, or published before 
1997, or written for other medical professions, or 
previous editions were excluded. 
Data were extracted into a standardized datasheet on 
title, editors, authors, publisher, year of publication, 
edition, categorization according to clinical discipline, 
any statements of conflict of interest, and sponsorship. 
If a sponsorship was stated, information was extracted 
on sponsor's name and of sponsor's involvement. 
We included all textbooks that were sponsored or that 
contained advertisements for drugs or medical devices.  
Survey 
For each sponsored textbook, we contacted the first-
mentioned editor and the first-mentioned author who 
was not also an editor. One author was a 
physiotherapist and as physiotherapists are not allowed 
to prescribe drugs, we chose the second author in this 
case. If a book had no description of editors (e.g. a book 
by a single author) or if it only described a technical 
editor (e.g. a non-physician without content knowledge) 
we regarded the authors as editors. We contacted these 
people in May 2008 via e-mail and asked them to fill in 
an anonymous web-based survey (SelectSurvey.NET 
1.5.4) with 10 questions and a unique ID code in case we 
needed to contact them for clarifications. We sent a 
reminder by e-mail after one week and by letter after 
three weeks. We excluded duplicate replies, guided by 
the respondents IP address.  
To investigate whether some textbooks without 
description of sponsorship were in fact sponsored, we 
did a second survey. In February 2009, we contacted the 
first-mentioned editors of the textbooks without 
sponsorship via e-mail and asked them to fill in an 
anonymous web-based survey (SelectSurvey.NET 1.5.4) 
regarding undisclosed sponsorship with 6 questions and 
a unique ID code in case we needed to contact them for 
clarifications. We sent a reminder by e-mail after 3 
weeks. 
Results 
We identified 118 textbooks for clinical courses in 
Danish at the University Medical Library (Figure 1). Fifty-
six were excluded: 9 were translations, 17 were 
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Figure 1. Flow chart of inclusion of textbooks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
intended for other professionals than physicians (e.g., 
nurses, physiotherapists and psychologists), 24 were 
published before 1997, 5 were previous editions, and 1 
was not a textbook, but a drug information guide. Of the 
62 remaining textbooks, 7 were sponsored and 
included. We found an additional 9 books at the 
University Medical Bookstore of which 4 were 
sponsored, giving a total of 11 included sponsored 
medical textbooks (15% of 71 books).13-23 
Nine textbooks only included the name of the sponsors 
whereas one textbook also included whole-page drug 
advertisements from the sponsoring companies. This 
textbook is also available for free if the doctor agrees to 
receive a visit from a drug representative from one of 
the sponsoring companies. One textbook for general 
practitioners did not indicate sponsorship in the version 
we identified for our study, but the sponsorship was 
known to us because of earlier correspondence with the 
editor. Furthermore, we discovered that an alternative 
version exists with a sponsorship statement and the 
company logo. Previously, this version could be 
obtained for free by contacting the sponsoring 
company, but it is now only available for free if the 
doctor agrees to receive a visit from the company’s drug 
representative. 
One textbook stated that the sponsors had no influence 
on the contents and recommendations, one that 
sponsorship included practical help and typing of 
manuscript, and four that the sponsorship covered 
printing cost and illustrations. The remaining 5 books 
had no such text. None of the books had any statements 
about editors’ and authors’ conflicts of interest. 
We sent the e-mail invitation to 11 editors, 10 of whom 
were also authors, and to 8 authors who were not also 
editors. We received 15 unique surveys (79% response 
rate), of which 14 were complete. Ten respondents 
were editors and 5 were authors, one of whom had 
filled in the incomplete survey. 
118 textbooks identified at the 
University Medical Library 
56 textbooks excluded 
   - 9 translations 
   - 17 intended for other professions 
   - 24 published before 1997 
   - 5 previous editions 
   - 1 not a real textbook 
 
62 textbooks reviewed 
55 non-sponsored textbooks excluded 
7 sponsored textbooks included 
 
4 additional sponsored textbooks included 
out of 9 additional textbooks identified at the 
University Medical Bookstore 
 
11 sponsored textbooks included 
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Initiation of sponsorship 
Table 1 describes the responses to the first survey 
concerning sponsored textbooks. In 8 out of 10 cases, 
the editors participated in initiating the contact with the 
sponsoring companies. Four of them additionally 
explained that they sought help with production costs, 
in part to allow for higher quality of illustrations, as 
medical textbooks in Danish are expensive due to the 
limited number of potential purchasers. In two cases, it 
was the publisher who wanted the book to be 
sponsored, and the editor had no influence on this 
decision. 
One out of 4 authors stated that he had had influence 
on whether the book should be sponsored, but not on 
who the sponsor should be. Two other authors stated 
that they did not know that the textbook they authored 
was sponsored before receiving our survey. 
Agreements with sponsoring companies 
Four out of the 10 editors and 1 out of 5 authors stated 
that they were presented with written information from 
the publisher that described the sponsor's influence, or 
lack thereof, on the editorial process and publication. 
Nine out of 10 editors stated there were no explicit 
terms in the agreement on sponsorship regarding
 
 
Table 1. Answers to survey about sponsorship of medical textbooks 
 
Respondents  Editors Authors* 
No. of invitations sent 
No. of responses received 
 11 
10 
8 
5 
 
Who took initiative to seek sponsorship? 
(more than one answer possible) 
Editors 
Co-authors 
Publisher 
Companies 
Other 
Don’t know 
8 
0 
5 
1 
0 
0 
1 
0 
0 
0 
0 
3 
Had you as an author or editor any influence on the decision to 
seek sponsorship? 
Yes 
No 
8 
2 
1 
3 
If yes, did you have any influence on who the sponsor should 
be? 
Yes 
No 
8 
0 
0 
1 
Were you as author or editor presented with written information from 
the publisher that described sponsors influence, or lack of, on the 
editorial process and publication? 
Yes 
No 
4 
6 
1 
4 
 
Agreement on sponsorship: 
No explicit terms 
Wanted to see chapter/book before agreement 
Other 
9 
1 
0 
4 
0 
0 
 
Which influence did the sponsor have on the editorial process? 
None 
Notify company with no explicit terms 
Notify company with right to comments 
Notify company with right to approval 
Other 
Don’t know 
8 
0 
1 
0 
1 
0 
1 
0 
0 
0 
0 
3 
Did you at any time have direct contact with the sponsor? Yes 
No 
8 
2 
0 
4 
 
Did you as author or editor receive fee from: 
 
Sponsors 
Publisher 
Other 
1 
9 
0 
0 
4 
0 
*One author did not respond to all questions in the survey 
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editorial independence, but in the last case some of the 
sponsoring firms wanted to see a draft of a chapter or 
the whole book before decision on sponsorship. 
Contacts with sponsoring companies after the 
agreement  
Two editors described that the sponsoring companies 
had contacted them after the agreement concerning the 
content of the textbook. In the first case, the editor had 
no influence on sponsorship, but was contacted by 
sponsoring companies approximately five times 
concerning questions in relation to the indication and 
choice of drug recommendations in specific chapters. 
The editor sent the questions to the authors of the 
specific chapters and stated that in no cases were the 
contents of the chapters changed.  
In the second case, the editor - who was also the sole 
author - had no direct contact with the sponsoring 
company, but was contacted indirectly through the 
publisher. The publisher wanted the author to rewrite a 
chapter concerning recommendations on a drug 
produced by the sponsoring company. The publisher 
stated that the indications for the drug were not 
updated with the current evidence, as the indications 
were broader than what the author had written. The 
publisher then supplied the author with 
recommendations that the author was sure originated 
from the sponsoring company. When the author asked 
the publisher if these recommendations came from the 
sponsoring company, the publisher denied it. The 
author then refused to change the contents and the 
publisher rewrote the chapter and threatened the 
author with legal action if he intervened. Due to the 
specific details of this answer the anonymity was broken 
and it was later verified through contact to the editor 
that this was the book where the sponsorship was 
concealed.  
Undisclosed sponsorship 
We sent an e-mail invitation to the first-mentioned 
editor of the 60 textbooks without any description of 
sponsorship and received 43 unique surveys (72% 
response rate), which were all complete. Forty replied 
that the textbook was not sponsored while 3 replied 
that they did not know. One of the editors who replied 
that the textbook was not sponsored stated that a 
previous edition from 1985 received industry support 
for production costs.  
 
Discussion 
We identified eleven sponsored medical textbooks in 
Danish for graduate clinical courses. We found that in 
most cases the editors initiated the sponsorship 
agreement to improve the graphical quality of the 
textbooks and lower sales prices, and that in most cases 
the sponsoring firms did not have any influence on the 
editorial process and the contents of the books. 
However, in one case the sponsoring companies 
contacted the authors regarding questions to the 
contents of the book, and in another case where 
sponsorship was concealed, the sponsoring company 
indirectly changed the contents of a chapter through 
contact with the publisher without the author’s 
approval. 
Our study is limited by its small sample, by being 
restricted to Danish medical textbooks and by our 
choice of surveying only some of the editors and 
authors. It can be debated whether our findings of 
sponsorship are related to the fact that Danish is only 
spoken by a small number of people. One editor replied 
that more than 1000 copies sold per year is considered a 
huge success, and another remarked that his estimated 
income from producing the book amounted to 12 US 
cents per hour. Editors and authors can therefore be 
tempted to seek sponsorship in order to compete with 
cheaper books written in English. Even so, we have 
identified serious problems of general interest that we 
discuss below.  
Unknown sponsorship 
In three cases, the editors of textbooks without 
statements about sponsorship did not know whether 
the textbook was sponsored. In two other cases the 
authors of sponsored textbooks firstly became aware of 
this fact when they received our survey. This lack of 
transparency is a serious oversight, as potential editors 
and authors have been deprived of the possibility to 
decline the invitation, due to the sponsorship, in order 
to protect their reputation and scientific integrity. 
Furthermore, authors obviously cannot state their 
conflicts of interest in future publications when they 
don't know about them, and they might therefore 
undeservedly become suspected of misconduct, or of 
having broken the rules they are expected to live up to. 
For example, the authors of an article that was 
published in the online version of the BMJ24 expressed 
concern subsequently25 that they had not been 
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informed that their paper was sponsored by a drug 
company. Underneath the series name ("Medical 
Milestones"), and almost as if it were part of the title of 
their paper, this text appeared: “Publication of this 
online supplement is made possible by an educational 
grant from Astra Zeneca”, and a drug ad was the banner 
along the top of the page. Two of the authors are 
Cochrane Centre Directors and questions had been 
raised with them about whether they had followed 
Cochrane policy regarding receiving support from 
industry. It is also problematic that concealed 
sponsorship makes it more difficult for authors to judge 
whether comments or requests for changes from the 
editors are sound or are commercially motivated. In one 
of our cases, the wish to change the contents of a 
chapter was only discovered as originating from the 
sponsor because of the author’s knowledge about 
concealed sponsorship of the textbook. 
A non-clinical textbook not included in our sample was 
"Rational Diagnosis and Treatment"26 that is an 
obligatory textbook for the course on theory in 
medicine. A previous edition27 was translated into 
Polish28, but it was not made clear at the outset that it 
would be sponsored. This was revealed to the second 
author when much of the translation had already taken 
place and when it was difficult to back out. The second 
author was one of us, and he would not have accepted 
the sponsorship if it had been discussed openly from the 
outset. The book is sponsored by Pfizer and Glaxo-Smith 
Kline, and this industry sponsorship is particularly 
unfortunate for this book, as it was written to promote 
the principles of evidence-based medicine. In contrast, 
the aim of the drug industry is to sell as many drugs to 
as many people as possible, and flawed research and 
marketing often leads to irrational prescribing and 
overprescribing.29   
Editorial independence and authorship 
In two cases the sponsor tried to influence the contents 
of the textbook. In one case, it was part of the 
agreement between the sponsors and the participating 
editor and authors that the sponsors were allowed to 
read the whole book or selected chapters and to 
comment on the contents before they decided whether 
they would sponsor the book. The authors were 
contacted approximately five times by the sponsoring 
companies with questions. While the editor stated that 
no changes were made, it is nevertheless problematic, 
as self-censorship might have occurred. Editors and 
authors may be tempted to spin the contents to attract 
sponsors and to avoid withdrawal of sponsorship. The 
latter seemed to be the problem in the second case 
where the sponsoring company by contacting the 
publisher accomplished changes to the contents of a 
chapter with recommendations on a drug produced by 
the company. We suggest that, at the very least, 
agreements regarding editorial processes, authorship 
and sponsorship should be  drawn up to support 
academic integrity, similar to authorship of scientific 
articles.30 Furthermore, medical textbooks should 
describe what the sponsorship covered, what the 
conditions were, and whether the sponsor had any 
influence on the text.  
Transparency of sponsorship 
Only one textbook had any statements about the 
sponsors’ influence on the editorial process, and five 
stated which production costs were covered by the 
sponsorship (e.g. secretarial assistance or graphical 
layout). None of the textbooks had any statements 
about the editors’ and authors’ ties to any of the 
sponsoring companies or companies that manufacture 
similar drugs or devices. This is problematic as medical 
textbooks may be more direct in their endorsement of 
specific treatments than research articles and seldom 
provide any data to back up recommendations. The 
readers must therefore rely on their trust in the editors 
and authors.  Ties to industry can affect 
recommendations31 and conflicts of interests can 
therefore also be a problem in non-sponsored books. 
This suggests that textbooks should contain conflict of 
interest statements for editors and authors. 
Conclusion 
Sponsorship of medical textbooks was not uncommon 
and while few editors and authors described any 
problems in relation to the sponsors’ possible influence 
on the contents, we discovered some major problems. 
We suggest that industry sponsorship of medical 
textbooks should be avoided, as it may lead to lack of 
academic freedom, for example through self-censorship. 
Medical students may be particularly vulnerable to 
commercial influences, as they have had little or no 
training in commercial biases and generally believe what 
they read in textbooks. If textbooks are sponsored they 
should at least live up to the same principles regarding 
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transparency and editorial independence as journal 
articles. Furthermore we recommend that all textbooks 
state any conflicts of interest for participating editors 
and authors. 
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